| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,255 |
1,162 |
$54K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,171 |
967 |
$48K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,211 |
1,133 |
$15K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
35 |
28 |
$550.43 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
54 |
49 |
$469.08 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
27 |
26 |
$418.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
111 |
95 |
$412.22 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
25 |
24 |
$41.18 |
| 36415 |
Collection of venous blood by venipuncture |
42 |
40 |
$9.60 |
| 80061 |
Lipid panel |
284 |
283 |
$0.00 |
| 3078F |
|
84 |
57 |
$0.00 |
| 83037 |
|
13 |
13 |
$0.00 |
| 3044F |
|
38 |
38 |
$0.00 |
| 3074F |
|
42 |
30 |
$0.00 |
| 91301 |
|
16 |
15 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
13 |
13 |
$0.00 |